(Q24239953)

20 October 2023

Madelon Pijls-Johannesma

7

object named as

Madelon Pijls-Johannesma

Madelon

Pijls-Johannesma

1 reference

20 October 2023

6

Dirk K M De Ruysscher

Dirk K M

De Ruysscher

1 reference

Ghislaine APG van Mastrigt

20 October 2023

3

object named as

Ghislaine APG van Mastrigt

Ghislaine A P G

van Mastrigt

1 reference

20 October 2023

Bram LT Ramaekers

2

Bram L T

Ramaekers

1 reference

20 October 2023

P Van den Ende

4

P

Van den Ende

1 reference

20 October 2023

J de Jong

5

J

de Jong

1 reference

Cochrane Database of Systematic Reviews

20 October 2023

language of work or name

1 reference

8 July 2009

0 references

published in

0 references

cites work

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

Erythropoietin increases hemoglobin in cancer patients during radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

A Phase II multi-institutional trial of chemoradiation using weekly docetaxel and erythropoietin for high-risk postoperative head and neck cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

Effectiveness of erythropoietin in the treatment of patients with malignancies: methods and preliminary results of a Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

Erythropoietin or Darbepoetin for patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

Oxygenation predicts radiation response and survival in patients with cervix cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

Clinical promise tempered by reality in the delivery of combined chemoradiation for common solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

Clinical application of recombinant human erythropoietin for treatments in patients with head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

7 January 2021

Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

7 January 2021

Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

7 January 2021

Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

7 January 2021

Hyperfractionated chemoradiation with carbogen breathing, with or without erythropoietin: a stepwise developed treatment schedule for advanced head-and-neck cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

7 January 2021

The effects of epoetin alfa on transfusion requirements in head and neck cancer patients: a prospective, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

7 January 2021

Do erythropoietin receptors on cancer cells explain unexpected clinical findings?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006158.PUB2

7 January 2021

10.1002/14651858.CD006158.PUB2

Identifiers

DOI

0 references

Fatcat ID

release_tsqpn6z3bng3potyrqwdrkso2e

0 references